The new data shows there were some 143,000 life science jobs in 2024, an increase of just 0.03% from 2023, according to the ...

A dual-track approach has gained momentum for biotech companies as capital markets remain volatile and acquirers become more ...

For all the attention on U.S.-China AI competition, new studies point to China’s rapid rise in biotechnology, especially for ...

We hoped industry layoffs would relent in 2024 ... So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech ...

The biotech industry experienced heady highs in early 2021, but has since suffered from a tight financial climate that has brought bankruptcies and widespread redundancies. Ben Hargreaves examines ...

The industry is showing its teeth, as companies have started slashing positions. Ben Hargreaves reviews how the job losses that started earlier in the biotech industry have quickly spread to all ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Biotechnology is a broad discipline in which ... developed by biotechnologists are useful in research, agriculture, industry and the clinic. Finding phenotypic variance that results from gene ...

Two Oregon high school athletes made headlines over the weekend after refusing to share the winners' podium with a transgender competitor at the girls’ high jump state championships. Reese ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.